Tea
OtherBlack tea infusion equivalent to approximately 530 mg total polyphenols expressed as gallic acid equivalents
NCT Number: NCT02328339
The study will explore the benefit of tea for microcirculation. Subjects will consume tea ar a placebo matched for taste and appearance in a blinded cross over design.
Looking for future studies?
Notify Me45 year–75 year
All sexes
Interventional
Not applicable
Epidemiological studies indicate that regular consumption of black tea reduces the risk of cardiovascular diseases. Tea consumption can result in improvements in endothelial function of conduit arteries as measured by flow mediated dilation.
Less is known however about its effects in other vascular beds. The study will test the hypothesis that tea affects endothelial function in the muscle microcirculation. This will be done by assessment of forearm blood flow using venous occlusion plethysmography after consumption of black tea against or placebo in a randomised, full cross-over study in 20 healthy middle-aged to elderly subjects
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Black tea infusion equivalent to approximately 530 mg total polyphenols expressed as gallic acid equivalents
Placebo matched to tea with respect to taste and appearance
Time frame: During acetylcholine infusion 120-140 min after first tea/placebo intake
Does tea ingestion change mean forearm blood flow response to acetylcholine when compared to placebo
Time frame: During sodium nitropusside infusion 170-190 min after first tea/placebo intake
Does tea ingestion change mean forearm blood flow response to sodium nitropusside when compared to placebo
Time frame: During L-NMMA infusion 220-240 min after first tea/placebo intake
Does tea ingestion change mean forearm blood flow response to L-NG-monomethyl Arginine (L-NMMA) when compared to placebo
Unilever R&D
Industry
Forearm Blood Flow Response to Acute Consumption of Black Tea
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06229873
Adherence, Treatment, Behavior
Boulder, Colorado, United States
View Trial DetailsNCT01575041
Blood Pressure, Cardiovascular Diseases
Wageningen, Netherlands
View Trial DetailsNCT05970601
Diabetes, Diabetes Mellitus
Düsseldorf, Germany
View Trial DetailsNCT06664281
Vascular Function
Beijing, China
View Trial Details